Possible association of acute lateral-wall myocardial infarction and bitter orange supplement.
about
STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literatureEphedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.Blood pressure and heart rate effects following a single dose of bitter orange.Determination of synephrine in bitter orange raw materials, extracts, and dietary supplements by liquid chromatography with ultraviolet detection: single-laboratory validation.Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update.The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.Natural products in anti-obesity therapy.Herbs-are they safe enough? an overview.An evidence-based systematic review of bitter orange (Citrus aurantium) by the Natural Standard Research Collaboration.Phytochemical compounds in sport nutrition: Synephrine and hydroxycitric acid (HCA) as examples for evaluation of possible health risks.Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects.Structural isomerization of synephrine influences its uptake and ensuing glutathione depletion in rat-isolated cardiomyocytes.Potential for toxicity with use of bitter orange extract and guarana for weight loss.Cardiovascular toxicity of Citrus aurantium in exercised rats.Heart Toxicity Related to Herbs and Dietary Supplements: Online Table of Case Reports. Part 4 of 5.Toxicological effects of a mixture used in weight loss products: p-synephrine associated with ephedrine, salicin, and caffeine.Perceived efficacy, indications, and information sources for medically indigent patients and their healthcare providers regarding dietary supplements.
P2860
Q24650985-221E3218-44A4-4E8F-8D0C-3E5E815A2A75Q33993947-0A8FF807-D122-429C-BEDB-7C92BAB3A052Q34471388-983A1C76-BB25-464A-8C20-79E845373E8CQ35513318-04CCC0E6-6CE6-4462-8501-B49E981645ABQ36377254-A06439B5-F86C-4E18-B2AB-4BF1DE7E66B6Q37863654-6565F1C8-5CD1-4A57-AAF6-F7D37467D473Q37899052-0D10A6B0-FC58-429E-9972-B62DDD2924E2Q38022683-5F9D2677-1F4E-49B3-BE6C-C509A7F3AC53Q38163000-37BD2D5C-58C7-403F-960F-6948C3ABBF56Q38921732-1115118B-09F7-4B6A-9B11-A5D601B57D1CQ40370414-8D4BCA6B-D7AF-4258-B439-BAA62A7DDCF7Q42782948-1112D99B-6007-41C4-8B54-0C95CD792BB3Q45229038-099A9ED6-94DD-4DCE-863A-ADECE4E68B59Q45414530-DBF24D51-7625-49B0-83D8-6F8FA6DDA1F4Q46294083-5BCDBED4-112D-4480-BEB5-165CDE75EACBQ47322199-3A6F6E10-F250-46DB-A33C-FF4B8FABCBF0Q50737946-B0B2ABAC-05AE-44AB-8633-996F4822DFEF
P2860
Possible association of acute lateral-wall myocardial infarction and bitter orange supplement.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Possible association of acute ...... and bitter orange supplement.
@ast
Possible association of acute ...... and bitter orange supplement.
@en
type
label
Possible association of acute ...... and bitter orange supplement.
@ast
Possible association of acute ...... and bitter orange supplement.
@en
prefLabel
Possible association of acute ...... and bitter orange supplement.
@ast
Possible association of acute ...... and bitter orange supplement.
@en
P2093
P2860
P356
P1476
Possible association of acute ...... and bitter orange supplement.
@en
P2093
Anthony L Compton
Diane L Nykamp
Majed N Fackih
P2860
P304
P356
10.1345/APH.1D473
P407
P577
2004-03-16T00:00:00Z